Autoimmune hemolytic anemia (AIHA) is a rare and potentially life-threatening condition. This article presents a case study of AIHA in a patient with a history of acute myelogenous leukemia in remission. Differentiating the cause and type of HA (extrinsic versus intrinsic) will be discussed, along with information on follow-up and refractory AIHA. Advanced practice RNs (APRNs) play an essential role in the early recognition of HA, as well as the diagnosis, referral, and management of the condition.
AT A GLANCE
- Unexplained normocytic or macrocytic anemia can be a sign of more serious conditions, such as AIHA.
- APRNs are important to the recognition and prompt treatment of the potentially life-threatening complications of HA.
- AIHA can often be managed with prednisone, but refractory cases may require additional treatment, such as immunotherapy or splenectomy.